“Pfizer Nutrition is an excellent strategic fit and this acquisition underlines our commitment to be the world’s leading nutrition, health and wellness company,” Nestle chief executive Paul Bulcke said in a statement.
The group added that the takeover would “complement our existing infant nutrition business perfectly.”
Nestle estimates that Pfizer Nutrition’s sales would reach about $2.4 billion in 2012.
Financial media have in the past weeks been speculating about an imminent acquisition by the Swiss group, which has significant funds after it sold eyecare giant Alcon to Novartis in 2010 for $51.6 billion.
© Copyright AFP Agence France-Presse GmbH – All rights reserved. This material may not be published, broadcast, rewritten or distributed. All reproduction or redistribution is expressly forbidden without the prior written agreement of AFP.
